Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study.

Guinn NR, Roberson RS, White W, Cowper PA, Broomer B, Milano C, Chiricolo A, Hill S.

Transfusion. 2015 Dec;55(12):2791-8. doi: 10.1111/trf.13246. Epub 2015 Jul 16.

PMID:
26183817
2.

Respiratory variation and cardiopulmonary interactions.

Roberson RS.

Best Pract Res Clin Anaesthesiol. 2014 Dec;28(4):407-18. doi: 10.1016/j.bpa.2014.09.001. Epub 2014 Sep 21.

PMID:
25480770
3.

Hypoventilation after inhaled anesthesia results in reanesthetization.

Leeson S, Roberson RS, Philip JH.

Anesth Analg. 2014 Oct;119(4):829-35. doi: 10.1213/ANE.0000000000000384. Erratum in: Anesth Analg. 2015 Aug;121(2):578.

PMID:
25099926
4.

Oral anticoagulants. New oral anticoagulants for atrial fibrillation: the factor Xa inhibitors rivaroxaban and apixaban.

Roberson RS, Shaw AD.

Rev Cardiovasc Med. 2012;13(1):e46-8. No abstract available.

PMID:
22565540
5.

Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers.

Roberson RS, Lockhart E, Shapiro NI, Bandarenko N, McMahon TJ, Massey MJ, White WD, Bennett-Guerrero E.

Transfusion. 2012 Nov;52(11):2459-64. doi: 10.1111/j.1537-2995.2012.03615.x. Epub 2012 Mar 27.

6.

Impact of red blood cell transfusion on global and regional measures of oxygenation.

Roberson RS, Bennett-Guerrero E.

Mt Sinai J Med. 2012 Jan-Feb;79(1):66-74. doi: 10.1002/msj.21284. Review.

7.

Expression of coxsackie and adenovirus receptor distinguishes transitional cancer states in therapy-induced cellular senescence.

Wu PC, Wang Q, Dong ZM, Chu E, Roberson RS, Ivanova IC, Wu DY.

Cell Death Dis. 2010 Sep 2;1:e70. doi: 10.1038/cddis.2010.47.

8.

Survivin and escaping in therapy-induced cellular senescence.

Wang Q, Wu PC, Roberson RS, Luk BV, Ivanova I, Chu E, Wu DY.

Int J Cancer. 2011 Apr 1;128(7):1546-58. doi: 10.1002/ijc.25482. Epub 2010 May 25.

9.

TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells.

Pan J, Zou J, Wu DY, Roberson RS, Hennings LJ, Ma X, Yared M, Blackburn ML, Chansky HA, Yang L.

Mol Cancer Res. 2008 May;6(5):862-72. doi: 10.1158/1541-7786.MCR-07-2070.

10.

Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes.

Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR.

Cell. 2005 Aug 12;122(3):337-49.

11.

Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.

Roberson RS, Kussick SJ, Vallieres E, Chen SY, Wu DY.

Cancer Res. 2005 Apr 1;65(7):2795-803.

12.
13.

African elephant sesquiterpenes. II. Identification and synthesis of new derivatives of 2,3-dihydrofarnesol.

Goodwin TE, Brown FD, Counts RW, Dowdy NC, Fraley PL, Hughes RA, Liu DZ, Mashburn CD, Rankin JD, Roberson RS, Wooley KD, Rasmussen EL, Riddle SW, Riddle HS, Schulz S.

J Nat Prod. 2002 Sep;65(9):1319-22.

PMID:
12350155
14.
15.
16.

Biochemical characterization of an active pyrophosphate-dependent phosphofructokinase from Treponema pallidum.

Roberson RS, Ronimus RS, Gephard S, Morgan HW.

FEMS Microbiol Lett. 2001 Jan 15;194(2):257-60.

Supplemental Content

Loading ...
Support Center